Sentence examples for biomarker in prostate cancer from inspiring English sources

Annexin A3 (ANXA3) was selected as protein target due to the fact that this is an emerging biomarker in prostate cancer.

Investigations of the prostate magnetic resonance imaging data resulted in locating a potential aggressiveness biomarker in prostate cancer.

This study builds on previous studies and generates evidence that contributes to qualification of BSI as an imaging biomarker in prostate cancer patients.

The bone scan index (BSI), obtained from planar whole-body bone scans, is the first quantitative imaging biomarker in prostate cancer and constitutes a surrogate for the tumor burden which is presented as a percentage of the total skeletal mass.

To our surprise, we have found which is perhaps the most famous biomarker in prostate cancer KLK3/PSA (Kallikrein-related peptidase 3), probe G_914588 (correlations of −0.9312 and −0.9000 respectively).

PDE4D7 has potential as a promising target for use as a biomarker in prostate cancer.

Most biomarkers in prostate cancer have only been evaluated in surgical cohorts.

Finally, very recently miRNAs have been suggested as potential biomarkers in prostate cancer.

In search for novel prognostic biomarkers in prostate cancer, we started with an unbiased assessment of accessible chromatin in prostate specimens.

The GSTP1 gene has been one of the most studied DNA methylation biomarkers in prostate cancer and is hypermethylated in >90% of cancers [57 67].

14 In this review, we discuss current concepts illustrating the need for novel biomarkers in prostate cancer and the potential for Cav-1 to fill this need.